Silvia Ottaviani

1.7k total citations
28 papers, 843 citations indexed

About

Silvia Ottaviani is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Silvia Ottaviani has authored 28 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Silvia Ottaviani's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (5 papers). Silvia Ottaviani is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (5 papers). Silvia Ottaviani collaborates with scholars based in United Kingdom, Italy and Germany. Silvia Ottaviani's co-authors include Justin Stebbing, Leandro Castellano, Jonathan Krell, Adam E. Frampton, R. Charles Coombes, Ling Peng, Manikandan Periyasamy, Loredana Pellegrino, Kui Xiao and Simak Ali and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Silvia Ottaviani

24 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Ottaviani United Kingdom 15 442 286 217 113 104 28 843
Ibrahim Y. Hachim United Arab Emirates 16 367 0.8× 119 0.4× 262 1.2× 133 1.2× 119 1.1× 56 815
Bin Qiao China 18 408 0.9× 188 0.7× 353 1.6× 68 0.6× 90 0.9× 36 874
Chitra Joseph United Kingdom 19 390 0.9× 262 0.9× 354 1.6× 65 0.6× 227 2.2× 36 923
Yan-qing Ding China 18 456 1.0× 172 0.6× 188 0.9× 43 0.4× 52 0.5× 71 747
Barry Jutten Netherlands 17 442 1.0× 266 0.9× 209 1.0× 38 0.3× 106 1.0× 19 804
Yao Xie China 13 308 0.7× 124 0.4× 276 1.3× 58 0.5× 103 1.0× 43 822
Souzan Najafi Iran 15 416 0.9× 254 0.9× 226 1.0× 60 0.5× 75 0.7× 35 726
Shu‐Biao Wu China 23 841 1.9× 457 1.6× 294 1.4× 63 0.6× 131 1.3× 55 1.2k
Leticia Serrano‐Oviedo Spain 16 409 0.9× 186 0.7× 139 0.6× 36 0.3× 123 1.2× 34 632

Countries citing papers authored by Silvia Ottaviani

Since Specialization
Citations

This map shows the geographic impact of Silvia Ottaviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Ottaviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Ottaviani more than expected).

Fields of papers citing papers by Silvia Ottaviani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Ottaviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Ottaviani. The network helps show where Silvia Ottaviani may publish in the future.

Co-authorship network of co-authors of Silvia Ottaviani

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Ottaviani. A scholar is included among the top collaborators of Silvia Ottaviani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Ottaviani. Silvia Ottaviani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ottaviani, Silvia, Luca Tagliafico, Marta Ponzano, et al.. (2024). Renal function assessment in older people: comparative analysis of estimation equation with serum creatinine. Frontiers in Medicine. 11. 1477500–1477500. 2 indexed citations
2.
Ottaviani, Silvia, Luca Tagliafico, Andrea Casabella, et al.. (2024). Measuring calf circumference in frail hospitalized older adults and prediction of in-hospital complications and post-discharge mortality. Frontiers in Medicine. 11. 1439353–1439353.
3.
Ottaviani, Silvia, Luca Tagliafico, Elena Page, et al.. (2024). Long-term survival in frail older adults sustaining a hip fracture: does the perioperative period really matter?. CINECA IRIS Institutial Research Information System (University of Genoa). 72(4). 193–203. 1 indexed citations
4.
Ottaviani, Silvia, Luca Tagliafico, Elena Page, et al.. (2024). Tipping the Balance Between Cognitive Reserve, Frailty, and Dementia in the Very Old?. Journal of Alzheimer s Disease. 101(4). 1227–1235.
5.
Tagliafico, Luca, et al.. (2024). Pain in non-communicative older adults beyond dementia: a narrative review. Frontiers in Medicine. 11. 1393367–1393367.
6.
Ottaviani, Silvia, et al.. (2022). How does the polymer architecture and position of cationic charges affect cell viability?. Polymer Chemistry. 14(3). 303–317. 14 indexed citations
7.
Peng, Ling, et al.. (2020). A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert Opinion on Drug Safety. 19(11). 1505–1511. 64 indexed citations
8.
Sims, Jonathan T., Venkatesh Krishnan, Sarah Engle, et al.. (2020). Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. Journal of Allergy and Clinical Immunology. 147(1). 107–111. 107 indexed citations
9.
Ottaviani, Silvia, Esther Ebstein, C. Lheure, et al.. (2020). Lung ultrasonography in patients with COVID-19: comparison with CT. Clinical Radiology. 75(11). 877.e1–877.e6. 16 indexed citations
10.
Ottaviani, Silvia & Justin Stebbing. (2020). What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials. Med. 1(1). 9–10. 2 indexed citations
11.
Richardson, Peter J., Silvia Ottaviani, A. Prelle, et al.. (2020). CNS penetration of potential anti-COVID-19 drugs. Journal of Neurology. 267(7). 1880–1882. 34 indexed citations
12.
Patel, Hetal, Manikandan Periyasamy, Georgina P. Sava, et al.. (2018). ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Molecular Cancer Therapeutics. 17(6). 1156–1166. 111 indexed citations
13.
Ottaviani, Silvia, Justin Stebbing, Adam E. Frampton, et al.. (2018). TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nature Communications. 9(1). 1845–1845. 101 indexed citations
14.
Castellano, Leandro, Aleksandra Dąbrowska, Loredana Pellegrino, et al.. (2017). Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR. Nucleic Acids Research. 45(8). gkx022–gkx022. 15 indexed citations
15.
Miller, Helen C, Adam E. Frampton, Anna Malczewska, et al.. (2016). MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. Endocrine Related Cancer. 23(9). 711–726. 55 indexed citations
16.
Cathcart, Paul, Walter Lucchesi, Silvia Ottaviani, et al.. (2015). Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease. Best Practice & Research Clinical Endocrinology & Metabolism. 29(4). 529–543. 15 indexed citations
17.
Krell, Jonathan, Adam E. Frampton, Reza Mirnezami, et al.. (2014). Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer. PLoS ONE. 9(6). e98561–e98561. 66 indexed citations
18.
Pellegrino, Loredana, Justin Stebbing, Vania Braga, et al.. (2013). miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Research. 41(10). 5400–5412. 96 indexed citations
19.
Alshaker, Heba, Lysann Sauer, Silvia Ottaviani, et al.. (2013). Therapeutic Potential of Targeting SK1 in Human Cancers. Advances in cancer research. 117. 143–200. 44 indexed citations
20.
Ottaviani, Silvia, Khadija Tahiri, Aline Frazier, et al.. (2009). Hes1, a new target for interleukin 1β in chondrocytes. Annals of the Rheumatic Diseases. 69(8). 1488–1494. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ibrahim Y. Hachim Breakdown of academic impact, for papers by Bin Qiao Breakdown of academic impact, for papers by Chitra Joseph Breakdown of academic impact, for papers by Yan-qing Ding Breakdown of academic impact, for papers by Barry Jutten Breakdown of academic impact, for papers by Yao Xie Breakdown of academic impact, for papers by Souzan Najafi Breakdown of academic impact, for papers by Shu‐Biao Wu Breakdown of academic impact, for papers by Leticia Serrano‐Oviedo
Rankless by CCL
2026